Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol in stable symptomatic COPD
NCT02547558Phase 4Unknown
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Oct 2015
- Primary completion
- Oct 2015
- Countries
- 1
01
Overview
Phase 4, open-label trial of indacaterol in chronic obstructive pulmonary disease (COPD), sponsored by Hospital Clínic de Barcelona. Primary endpoint: Arterial Oxygen Tension. Status: unknown.
02
Drugs
indacaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02547558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02547558.